Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal JFL : Jurnal Farmasi Lampung JURNAL FARMASIMED (JFM)
Ilahi, Ade Rezki
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluation of the Drug Receiving and Storage System at Pharmacy X in Bandung City Based on Technical Instructions for PharmaceuticalService Standards at Pharmacies Ilahi, Ade Rezki; Yoppi Iskandar
Jurnal FARMASIMED (JFM) Vol 8 No 1 (2025): Jurnal Farmasimed (JFM)
Publisher : Fakultas Farmasi Institut Kesehatan Medistra Lubuk Pakam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35451/m3f96783

Abstract

Background: Discrepancies in the quantity of drugs received, damaged packaging, and improper storage that fails to consider drug stability are some of the common issues encountered. Objective: This study aims to evaluate the drug receiving and storage systems at Pharmacy X in Bandung City based on the Technical Guidelines for Pharmaceutical Service Standards in accordance with the Regulation of the Minister of Health No. 73 of 2016. Method: The method used was descriptive observational with a prospective approach through direct observation, interviews, and documentation. Evaluation was conducted on both technical and administrative parameters in the receiving and storage of pharmaceutical preparations. Results: The study showed that the drug receiving system achieved a compliance rate of 85.7%, and the drug storage system achieved 94.44%, both categorized as “Excellent.” Pharmacy X has properly implemented procedures for physical verification, invoice data matching, expiration date and batch number checks. Additionally, drug storage follows the FIFO and FEFO principles, grouping based on dosage forms, and monitoring of room and refrigerator temperatures. The use of an electronic recording system further enhances stock management accuracy and efficiency. This pharmacy has demonstrated compliance with established standards and implemented patient safety principles in pharmaceutical management. These findings indicate that Pharmacy X can serve as a model for professional and high-quality pharmaceutical practice. Conclusion: The implementation of pharmaceutical service standards has been proven to improve service quality and the efficiency of drug distribution systems at the community pharmacy level.
Potassium-Competitive Acid Blocker (P-CAB) Generasi Baru: Studi Farmakologi dan Klinis Vonoprazan Fumarate: A New Generation of Potassium-Competitive Acid Blockers (P-CAB): Pharmacological and Clinical Studies of Vonoprazan Fumarate Ilahi, Ade Rezki; Febrina, Ellin
JFL : Jurnal Farmasi Lampung Vol. 14 No. 2 (2025): JFL : Jurnal Farmasi Lampung
Publisher : Program Studi Farmasi-Fakultas Matematika dan Ilmu Pengetahuan Alam-Universitas Tulang Bawang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37090/hf4n3x55

Abstract

The aim of this study was to determine the pharmacological profile, clinical effectiveness, and safety of Vocinti (vonoprazan fumarate) as a P-CAB class gastric acid secretion inhibitor therapy. The method used was a literature review with a qualitative-descriptive approach. Information was collected, manually sorted and critically reviewed to ensure its validity and relevance, in order to produce a comprehensive picture of the pharmacological aspects, clinical effectiveness, and safety of Vocinti use. Based on the available literature review, Vocinti (vonoprazan fumarate) as a P-CAB class gastric acid secretion inhibitor therapy shows a superior pharmacological profile compared to conventional PPIs. Vonoprazan works through reversible competitive inhibition of the H+/K+-ATPase enzyme, resulting in faster, stronger, and more consistent acid suppression, with a longer duration of action and independence from acid activation. Thus, vonoprazan is worthy of consideration as an alternative primary therapy for gastric acid disorders, especially in refractory patients or those requiring long-term therapy. Keywords: P-CAB, Vonoprazan Fumarate Clinical, Pharmacological Studies, Vocinti
Co-Authors Ellin Febrina Yoppi Iskandar